Cookies Disclaimer

This site uses cookies to analyse traffic, remember your preferences, and optimise your experience.

Skip to main content
Navigate to the Gilbert + Tobin Homepage
Navigate to the Gilbert + Tobin Homepage
  • Option
  • Option - Consequat incididunt ad incididunt enim reprehenderit
  • Option
Navigate to the Gilbert + Tobin Homepage
  • Our people
    • Agribusiness
    • Consumer and Retail
    • Defence
    • Energy
    • Financial Services
    • Government
    • Healthcare and Life Sciences
    • Infrastructure
    • Metals and Mining
    • Private Capital
    • Professional Services
    • Real Assets
    • Social and Impact Investing
    • Superannuation
    • Technology
    • Transport and Logistics
    • Artificial Intelligence
    • Banking and Finance
    • Capital Markets
    • Charities and Not-For-Profit Law
    • Climate Change and Sustainability
    • Competition, Consumer and Market Regulation
    • Corporate Advisory
    • Cyber Security
    • Disputes and Investigations
    • Employment
    • Environment and Planning
    • Financial Services Regulation
    • Foreign Investment in Australia
    • Fund Formation
    • G+T Innovate
    • Intellectual Property
    • Mergers and Acquisitions
    • Native Title, Heritage and Agreements
    • Privacy and Data
    • Private Capital
    • Pro Bono
    • Projects and Construction
    • Real Estate
    • Restructuring Advisory
    • Tax
    • Technology and Digital
    • Ventures and Startups
    • Digital infrastructure in Australia
    • Takeovers and schemes review 2026
    • Australia’s new merger regime
    • Beyond transition: shaping Australia’s energy future
    • Financial services regulatory reform
    • Sustainability Insights
  • News
  • Contact us
Insights

Health AI: UK study of real world examples of bias

Date published 29 May 2024
Read time TBC
In early March 2024, the UK Government released a report by an independent expert panel into equity in medical devices.The inquiry was triggered by concerns that a medical device called a pulse oximeter, which clips on the end of your finger and estimates the level of oxygen in the blood by sending light through the skin, tends to overestimate oxygen levels in non-White patients. During the COVID pandemic, this could have delayed hospitalisation and use of oxygen for non-White patients.
 

On this page navigation

Share

Share on LinkedIn Email article

Related sectors

Healthcare and Life Sciences

Related services

Artificial Intelligence
Get in touch
Contact us
Gilbert + Tobin acknowledges Australia’s First Nations peoples as the Traditional Custodians of this land. We pay our respects to Elders, both past and present, and extend that respect to all First Nations peoples across these lands.
  • Subscribe to our content
  • Manage your subscription
  • Privacy Policy
  • Terms of use
  • Standard Terms of Engagement
  • AML/CTF reform – our approach
  • Modern Slavery Statement
  • Whistleblowers
  • LinkedIn
  • Twitter
© Gilbert + Tobin 2026